Related Experiment Video
Updated: Dec 3, 2025

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
Association Between Human Papilloma Virus Infection and Malignant Sinonasal Inverted Papilloma
Ronghua Ding1, Qiaorong Sun2, Yong Wang1
1Department of Otorhinolaryngology, Taizhou Second People's Hospital of Jiangsu Province, Taizhou, China.
Objective:
This systematic review and meta-analysis aimed to evaluate the risk of malignant sinonasal inverted papilloma (SNIP) according to the type of human papilloma virus (HPV) infection.
Methods:
The databases of PubMed, EmBase, and Web of Science were searched for studies that reported the risk of malignant SNIP in patients infected by specific types of HPV. The quantitative analyses for pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated.
Results:
Twenty-six molecular epidemiological studies that recruited a total of 900 patients with SNIP were selected for the final meta-analysis. The summary ORs indicated that HPV-6 (OR: 2.02; 95% CI: 0.47-8.61; P = .343), HPV-11 (OR: 0.86; 95% CI: 0.26-2.89; P = .806), and HPV-6/11 (OR: 1.44; 95% CI: 0.59-3.53; P = .426) infections were not associated with the risk of malignant SNIP. However, the risk of malignant SNIP was increased in patients infected with HPV-16 (OR: 8.51; 95% CI: 3.36-21.59; P < .001), HPV-11/16 (OR: 7.95; 95% CI: 1.13-56.01; P = .038), HPV-18 (OR: 23.26; 95% CI: 5.27-102.73; P < .001), and HPV-16/18 (OR: 24.34; 95% CI: 5.74-103.18; P < .001).
Conclusions:
This study found that patients infected with HPV types 16, 11/16, 18, and 16/18 were associated with an increased risk of malignant SNIP. However, patients infected with HPV types 6, 11, and 6/11 did not have a significant risk of malignant SNIP. Laryngoscope, 131:1200-1205, 2021.
Insights
Human papillomavirus (HPV) types 16, 18, and their combinations significantly increase the risk of malignant sinonasal inverted papilloma (SNIP). However, HPV types 6 and 11 do not show a significant association with malignant SNIP development.
Area of Science:
- Otolaryngology
- Oncology
- Virology
Background:
- Sinonasal inverted papilloma (SNIP) is a benign tumor with a potential for malignant transformation.
- Human papillomavirus (HPV) infection is implicated in the pathogenesis of various head and neck cancers.
- The specific role of different HPV types in the malignant progression of SNIP requires further clarification.
Purpose of the Study:
- To systematically review and meta-analyze the association between specific HPV types and the risk of malignant transformation in SNIP.
- To quantify the risk of malignant SNIP based on HPV infection status.
Main Methods:
- A systematic literature search was conducted across PubMed, EmBase, and Web of Science databases.
- Molecular epidemiological studies reporting HPV types and malignant SNIP risk were included.
- Quantitative meta-analysis was performed to calculate pooled odds ratios (ORs) and 95% confidence intervals (CIs).
Main Results:
- Twenty-six studies comprising 900 SNIP patients were analyzed.
- HPV types 16, 18, HPV 11/16, and HPV 16/18 infections were significantly associated with an increased risk of malignant SNIP (ORs ranging from 7.95 to 24.34).
- HPV types 6, 11, and HPV 6/11 infections did not demonstrate a statistically significant association with malignant SNIP risk.
Conclusions:
- HPV types 16 and 18 are key oncogenic drivers associated with malignant transformation of SNIP.
- Patients with SNIP infected by HPV types 16, 18, 11/16, or 16/18 face a substantially elevated risk of developing malignant disease.
- Further research may focus on HPV-targeted therapies for SNIP management.
More Related Videos
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers
Abnormal Proliferation

